Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

PRISTIQ®(desvenlafaxine succinate)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

PRISTIQ® Quick Finder

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the...
Did you find an answer to your question? Yes No

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show...

Did you find an answer to your question? Yes No

1 INDICATIONS AND USAGE

PRISTIQ is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)].

Did you find an answer to your question? Yes No

2 DOSAGE AND ADMINISTRATION

2.1 General Instructions for Use

The recommended dose for PRISTIQ is 50 mg once daily, with or without food. The 50 mg dose is both a...

Did you find an answer to your question? Yes No

3 DOSAGE FORMS AND STRENGTHS

  • 25 mg Tablet: tan, square pyramid tablet debossed with "W" over "25" on the flat side
  • 50 mg Tablet: light pink, square pyramid tablet debossed with "W" over "50" on the flat side...
Did you find an answer to your question? Yes No

4 CONTRAINDICATIONS

  • Hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or to any excipients in the PRISTIQ formulation. Angioedema has been reported in patients treated with PRISTIQ...
Did you find an answer to your question? Yes No

5 WARNINGS AND PRECAUTIONS

5.1 Suicidal Thoughts and Behaviors in Pediatric and Young Adult Patients

Patients with MDD, both adult and pediatric, may experience...

Did you find an answer to your question? Yes No

6 ADVERSE REACTIONS

The following adverse reactions are discussed in greater detail in other sections of the label.

  • Hypersensitivity [see

    6.1 Clinical Studies Experience...

Did you find an answer to your question? Yes No

7 DRUG INTERACTIONS

7.1 Drugs Having Clinically Important Interactions with PRISTIQ

Table 8: Clinically Important Drug Interactions with PRISTIQ...
Did you find an answer to your question? Yes No

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Pregnancy Exposure Registry

There is...

Did you find an answer to your question? Yes No

9 DRUG ABUSE AND DEPENDENCE

9.1 Controlled Substance

PRISTIQ is not a controlled substance.

Did you find an answer to your question? Yes No

10 OVERDOSAGE

10.1 Human Experience with Overdosage

There is limited clinical trial experience with desvenlafaxine succinate overdosage in humans. However,...

Did you find an answer to your question? Yes No

11 DESCRIPTION

PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine (O-desmethylvenlafaxine) is the major...

Did you find an answer to your question? Yes No

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

The exact mechanism of the antidepressant action of desvenlafaxine is unknown, but is thought to be related to the...

Did you find an answer to your question? Yes No

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

...

Did you find an answer to your question? Yes No

14 CLINICAL STUDIES

Major Depressive Disorder

The efficacy of PRISTIQ as a treatment for depression was established in four 8-week,...

Did you find an answer to your question? Yes No

16 HOW SUPPLIED/STORAGE AND HANDLING

PRISTIQ® (desvenlafaxine) extended-release tablets are available as follows:

25 mg, tan, square pyramid tablet debossed with "W" (over) "25" on the flat...

Did you find an answer to your question? Yes No
...
This Medication Guide has been approved by the U.S. Food and Drug Administration.Revised: 7/2021
Did you find an answer to your question? Yes No

This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.

...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No

Resources

PRISTIQ Co-Pay Card
For questions regarding the PRISTIQ Co-Pay Card, please call (855) 440-6852
Didn’t find what you were looking for? Contact us.
Report Adverse Event